The roles of MCP-1 and protein kinase Cδ activation in human eosinophilic leukemia EoL-1 cells
The roles of MCP-1 and protein kinase Cδ activation in human eosinophilic leukemia EoL-1 cells
复制标题
DOI:
10.1016/j.cyto.2009.07.008
复制
发表时间:
2009-12-01
期刊:
影响因子:
3.8
通讯作者:
Kim, In Sik
中科院分区:
文献类型:
--
作者:
Lee, Ji-Sook;Yang, Eun Ju;Kim, In Sik
Idiopathic hypereosinophilc syndrome is a disorder associated with clonally eosinophilic proliferation. The importance of FIP1-like-1-platelet-derived growth factor receptor-alpha (FIP1L1-PDGFRA) in the pathogenesis and classification of HES has been recently reported. In this study, we investigated the contribution of monocyte chemoattractant protein-1 (MCP-1)/CCL2 to chemotactic activity and protein kinase C delta (PKC delta in the human eosinophilic leukemia cell line EoL-1. These cells express CCR2 protein among the CC chemokine receptors (CCR1-5). MCP-1 induces strong migration of EoL-1 cells and the chemotaxis signal in response to MCP-1 involves a G(i)/G(o) protein, phospholipase C (PLC), PKC delta, p38 MAPK and NF-kappa B. MCP-1 activates p38 MAN via G(i)/G(o) protein, PLC and PKC delta cascade. MCP-1 also induces NF-kappa B translocation and the activation is inhibited by PKC delta activation. The increase in the basal expression and activity of PKC delta in EoL-1 cells, compared to normal eosinophils, inhibits apoptosis in EoL-1 cells. Anti-apoptotic mechanism of PKC delta is related to inhibition of caspase 3 and caspase 9, but not to FIP1L1-PDGFRA. PKC delta functions as an anti-apoptotic molecule, and is involved in EoL-1 cell movement stimulated by MCP-1. This study contributes to an understanding of MCP-1 in eosinophil biology and pathogenic mechanism of eosinophilic disorders. (C) 2009 Elsevier Ltd. All rights reserved.